Otros idiomas BioAdaptives, Inc.

Acciones

BDPT

US09072U1079

Mercado cerrado - OTC Markets Otros sitios de cotización 21:59:04 16/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,0005 ^USD	0,00 %		+25,00 %	0,00 %

10/04	BioAdaptives, Inc. informa de los resultados de las ganancias para el año completo finalizado el 31 de diciembre de 2023	CI
22/02	Bioadaptives, Inc. anuncia Naturacomplete?, un suplemento "todo en uno" para optimizar su sistema de control de la obesidad basado en Ai FYO	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	10/04
BioAdaptives, Inc. Announces NaturaComplete™, an All-In-One Supplement to Optimize Its AI-Based FYO Obesity Management System	22/02
Bioadaptives, Inc. Announces Naturacomplete?, an All-In-One Supplement to Optimize Its Ai-Based FYO Obesity Management System	22/02
BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management	01/02
BioAdaptives Announces Signing of a New Distributor’s Agreement for AI Body Composition Measuring App and New Weight Management System	17/01
BioAdaptives Announces Signing of a New Distributor?s Agreement for AI Body Composition Measuring App and New Weight Management System	17/01
Livestock Impact, Inc., Subsidiary of BioAdaptives, Inc., Launches Innovative Food Lab for Development of Treats and Supplement Powder for Human, Equine, and Canine Products	04/01
BioAdaptives, Inc. to Form New Division, AI BodyShape Lab, to Promote Adult Fitness and Weight Management	21/12
BioAdaptives, Inc. Introduces PROTEINnMORETM Ahead of 2024 Launch of AI-based “Fit Your Outfit” app	14/12
BioAdaptives Inc. Announces the Development of PROTEINnMORETM	14/12
BioAdaptives Announces Special Holiday Wellness Offers and Gift	07/12
BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula	16/11
BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula	16/11
BioAdaptives, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
BioAdaptives Highlights Continued Success of Popular LUNG ARMOR™ System as US Enters Flu Season	09/11
BioAdaptives, Inc. Highlights Continued Success of Popular LUNG ARMOR System as US Enters Flu Season	09/11
BioAdaptives Takes Aim at Safe Pain Management with All-Natural Supplement	02/11
BioAdaptives Targets Multi-Billion Dollar Sleep Market with SleepEZ™ Natural Supplement	26/10/23
BioAdaptives, Inc. Celebrates Nine Years of Commercial Success in Equine Nutrition	12/10/23
BioAdaptives, Inc. Announces Nationwide Launch of Lung Fortress Natural Supplement	10/10/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas BioAdaptives, Inc.

Acciones

BDPT

US09072U1079

Otros idiomas

Filtros